PBM - Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. Common Shares Logo

PBM - Psyence Biomedical Ltd. Common Shares

https://www.psyencebiomed.com
Recent News
Powered by Alpha Vantage
Neutral
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein
GlobeNewswire • 5 months, 3 weeks ago • score: 0.09
TORONTO, March 25, 2025 ( GLOBE NEWSWIRE ) -- Psyence Group Inc ( "Psyence Group" or the "Company" ) ( CSE: PSYG ) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd ( NASDAQ: PBM ) ( "PBM" or "Psyence Biomed" ) , has announced that it has expanded its newly created Scientific ...
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$125.40
52W Low
$2.36
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.18
Valuation
Attractive
As of 2024-12-31 (Overview)
Trailing P/E (<15 better)
0.06
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
1.17
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
0.09
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
0.48%
Institutions (25–75% balanced)
44.69%
Shares Outstanding
234,280
Float
70,360
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2024-12-31 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
41.76
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—